These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27693615)

  • 1. Variegated RHOA mutations in human cancers.
    Kataoka K; Ogawa S
    Exp Hematol; 2016 Dec; 44(12):1123-1129. PubMed ID: 27693615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
    O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
    Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
    Nagata Y; Kontani K; Enami T; Kataoka K; Ishii R; Totoki Y; Kataoka TR; Hirata M; Aoki K; Nakano K; Kitanaka A; Sakata-Yanagimoto M; Egami S; Shiraishi Y; Chiba K; Tanaka H; Shiozawa Y; Yoshizato T; Suzuki H; Kon A; Yoshida K; Sato Y; Sato-Otsubo A; Sanada M; Munakata W; Nakamura H; Hama N; Miyano S; Nureki O; Shibata T; Haga H; Shimoda K; Katada T; Chiba S; Watanabe T; Ogawa S
    Blood; 2016 Feb; 127(5):596-604. PubMed ID: 26574607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.
    Chiba S; Enami T; Ogawa S; Sakata-Yanagimoto M
    Small GTPases; 2015; 6(2):100-3. PubMed ID: 26103434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHOA Therapeutic Targeting in Hematological Cancers.
    Santos JC; Profitós-Pelejà N; Sánchez-Vinces S; Roué G
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine.
    Hu L; Zhang X; Zang S
    Cancer Biol Med; 2024 Aug; 21(9):754-68. PubMed ID: 39119774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHOA takes the RHOad less traveled to cancer.
    Schaefer A; Der CJ
    Trends Cancer; 2022 Aug; 8(8):655-669. PubMed ID: 35568648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases.
    Ushiku T; Ishikawa S; Kakiuchi M; Tanaka A; Katoh H; Aburatani H; Lauwers GY; Fukayama M
    Gastric Cancer; 2016 Apr; 19(2):403-411. PubMed ID: 25823974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
    Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
    Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk.
    Ung CY; Li H; Ma XH; Jia J; Li BW; Low BC; Chen YZ
    FEBS Lett; 2008 Jun; 582(15):2283-90. PubMed ID: 18505685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multistep tumorigenesis in peripheral T cell lymphoma.
    Sakata-Yanagimoto M
    Int J Hematol; 2015 Nov; 102(5):523-7. PubMed ID: 25628103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrent mutations in RHOA and FYN in peripheral T cell lymphomas].
    Couronné L; Bastard C; Bernard OA
    Med Sci (Paris); 2014 May; 30(5):488-92. PubMed ID: 24939529
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway.
    Marinissen MJ; Chiariello M; Gutkind JS
    Genes Dev; 2001 Mar; 15(5):535-53. PubMed ID: 11238375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells.
    Li B; Antonyak MA; Zhang J; Cerione RA
    Oncogene; 2012 Nov; 31(45):4740-9. PubMed ID: 22266864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insert region of RhoA is essential for Rho kinase activation and cellular transformation.
    Zong H; Kaibuchi K; Quilliam LA
    Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
    Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GOLPH3 regulates the migration and invasion of glioma cells though RhoA.
    Zhou X; Zhan W; Bian W; Hua L; Shi Q; Xie S; Yang D; Li Y; Zhang X; Liu G; Yu R
    Biochem Biophys Res Commun; 2013 Apr; 433(3):338-44. PubMed ID: 23500462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.